
Oxford–AstraZeneca COVID-19 vaccine efficacy
2020 has been a difficult year for all, but has seen 58 vaccines against severe acute respiratory syndrome coronavirus 2...
2020 has been a difficult year for all, but has seen 58 vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) be developed and in clinical trials, with some vaccines reportedly having more than 90% efficacy against COVID-19 in clinical trials. This remarkable achievement is much-needed good news as COVID-19 cases are currently at their highest daily levels globally. New vaccine efficacy results are reported now in The Lancet: investigators of four randomized, controlled trials conducted in the UK, South Africa, and Brazil...
0 comments
Read more